Gene · 5798
Papers3,241
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 3,241
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrative structural modelling and visualisation of a cellular organelle. | QRB Discov | 2022 | 37529283 | PubTator, text mining | PubMed |
| Increased Frequency of Diabetic Ketoacidosis: The Link With COVID-19 Pandemic. | Front Clin Diabetes Healthc | 2022 | 36992744 | PubTator, text mining | PubMed |
| A Case of Mody 2 - Associated Hyperglycemia Diagnosed as Gestational Diabetes. | Balkan J Med Genet | 2022 | 36880032 | PubTator, text mining | PubMed |
| Hereditable variants of classical protein tyrosine phosphatase genes: Will they prove innocent or guilty? | Front Cell Dev Biol | 2022 | 36755664 | PubTator, text mining | PubMed |
| Integrated analysis of transcription factor-mRNA-miRNA regulatory network related to immune characteristics in medullary thyroid carcinoma. | Front Immunol | 2022 | 36713370 | PubTator, text mining | PubMed |
| Graves disease is more prevalent than Hashimoto disease in children and adolescents with type 1 diabetes. | Front Endocrinol (Lausanne) | 2022 | 36704033 | PubTator, text mining | PubMed |
| Characterizing T cell responses to enzymatically modified beta cell neo-epitopes. | Front Immunol | 2022 | 36703975 | PubTator, text mining | PubMed |
| Stratified glucose-lowering response to vildagliptin and pioglitazone by obesity and hypertriglyceridemia in a randomized crossover trial. | Front Endocrinol (Lausanne) | 2022 | 36699039 | PubTator, text mining | PubMed |
| Regeneration of Pancreatic β-Cells for Diabetes Therapeutics by Natural DYRK1A Inhibitors. | Metabolites | 2022 | 36676976 | PubTator, text mining | PubMed |
| Pathogenesis Study of Glioma: From Glioma Stem Cells, Genomic Tags, to Rodent Models. | Brain Sci | 2022 | 36672013 | PubTator, text mining | PubMed |
| INSR novel mutations identified in a Chinese family with severe INSR-related insulin resistance syndromes: A case report. | Medicine (Baltimore) | 2022 | 36626508 | PubTator, text mining | PubMed |
| Roles of extracellular vesicles associated non-coding RNAs in Diabetes Mellitus. | Front Endocrinol (Lausanne) | 2022 | 36619588 | PubTator, text mining | PubMed |
| Prognostic value of TMEM59L and its genomic and immunological characteristics in cancer. | Front Immunol | 2022 | 36618425 | PubTator, text mining | PubMed |
| Current Knowledge on the Pathophysiology of Lean/Normal-Weight Type 2 Diabetes. | Int J Mol Sci | 2022 | 36614099 | PubTator, text mining | PubMed |
| Evolutionary Analysis of TCGA Data Using Over- and Under- Mutated Genes Identify Key Molecular Pathways and Cellular Functions in Lung Cancer Subtypes. | Cancers (Basel) | 2022 | 36612014 | PubTator, text mining | PubMed |
| Autoimmune reaction against pancreatic beta cells in children and adolescents with simple obesity. | Front Endocrinol (Lausanne) | 2022 | 36589801 | PubTator, text mining | PubMed |
| A new thinking: deciphering the aberrance and clinical implication of copper-death signatures in clear cell renal cell carcinoma. | Cell Biosci | 2022 | 36581992 | PubTator, text mining | PubMed |
A randomized trial of oral gamma aminobutyric acid (GABA) or the combination of GABA with glutamic acid decarboxylase (GAD) on pancreatic islet endocrine function in children with newly diagnosed type 1 diabetes. | Nat Commun | 2022 | 36566274 | PubTator, text mining | PubMed |
| Immune cell-derived extracellular vesicular microRNAs induce pancreatic beta cell apoptosis. | Heliyon | 2022 | 36561684 | PubTator, text mining | PubMed |
| Diagnostic Accuracy of Methods for Detection of Antibodies against Type I Interferons in Patients with Endocrine Disorders. | J Pers Med | 2022 | 36556169 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5798/papers?page=19